Vitamin Metabolizma Bozuklukları
Özet
Vitamin metabolizma bozuklukları, vitaminlerin emilim, taşıma ve aktivasyon süreçlerindeki genetik aksaklıklardan kaynaklanan ve sistemik veya nörolojik tutulumla seyreden ciddi hastalıklardır. Tiamin, riboflavin, B6 ve folat gibi temel vitaminlerin metabolizmasındaki spesifik gen mutasyonları, nörolojik sekellere ve hayatı tehdit eden ensefalopati ataklarına yol açabilmektedir. Erken tanı ve uygun vitamin takviyesi ile bu hastalıkların yarattığı nörolojik hasarların önlenmesi veya klinik tablonun dramatik şekilde iyileştirilmesi mümkündür.
Vitamin metabolism disorders are serious conditions caused by genetic defects in the absorption, transport, and activation of vitamins, resulting in systemic or neurological involvement. Specific gene mutations in the metabolism of essential vitamins such as thiamine, riboflavin, B6, and folate can lead to neurological sequelae and life-threatening episodes of encephalopathy. Early diagnosis and appropriate vitamin supplementation can prevent neurological damage and dramatically improve the clinical condition in these disorders.
Referanslar
Plecko B, Steinfeld R. Disorders of vitamin metabolism. In: Swaiman KF, Ashwal S, Ferriero DM, eds. Swaiman's Pediatric Neurology. Principles and Practice. 6th ed. Philadelphia: Mosby Elsevier; 2017:e927-e951.
Dhir S, Tarasenko M, Napoli E, Giulivi C. Neurological, Psychiatric, and Biochemical Aspects of Thiamine Deficiency in Children and Adults. Front Psychiatry. 2019;10:207.
Marcé-Grau A, Martí-Sánchez L, Baide-Mairena H, Ortigoza-Escobar JD, Pérez-Dueñas B. Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies. J Inherit Metab Dis. 2019;42(4):581-597.
Bergmann AK, Sahai I, Falcone JF et al. Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update. J Pediat. 2009;155: 888-892.
Akın L, Kurtoğlu S, Kendirci M, Akın MA, Karakükçü M. Does early treatment prevent deafness in thiamine-responsive megaloblastic anaemia syndrome? J Clin Res Pediatr Endocrinol. 2011;3(1):36-39.
Tabarki B, Al-Shafi S, Al-Shahwan S et al. Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings. Neurology. 2013;80(3):261-267.
Ortigoza-Escobar JD, Alfadhel M, Molero-Luis M et al. Thiamine deficiency in childhood with attention to genetic causes: Survival and outcome predictors. Ann Neurol. 2017;82(3):317-330.
Ortigoza-Escobar JD, Molero-Luis M, Arias A, et al. Free-thiamine is a potential biomarker of thiamine transporter-2 defi- ciency: a treatable cause of Leigh syndrome. Brain. 2016;139(Pt 1:31-38.
Kamaşak T, Havalı C, İnce H et al. Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease? Eur J Paediatr Neurol. 2018;22(6):1139-1149.
Kelley RI, Robinson D, Puffenberger EG, Strauss KA, Morton DH. Amish lethal microcephaly: a new metabolic disorder with severe congenital microcephaly and 2-ketoglutaric aciduria. Am J Med Genet. 2002;112:318-326.
Spiegel R, Shaag A, Edvardson S, et al. SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis. Ann Neurol. 2009;66(3):419-424.
Banka S, de Goede C, Yue WW, et al. Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations. Mol Genet Metab. 2014;113(4):301-306.
Balasubramaniam S, Christodoulou J, Rahman S. Disorders of riboflavin metabolism. J Inherit Metab Dis. 2019;42(4):608-619.
Barile M, Giancaspero TA, Leone P, Galluccio M, Indiveri C. Riboflavin transport and metabolism in humans. J Inherit Metab Dis. 2016;39(4):545-557.
Green P, Wiseman M, Crow YJ, et al. Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in C20ORF54. Am J Hum Genet. 2010;86:485-489.
Bosch AM, Stroek K, Abeling NG, Waterham HR, Ijlst L, Wanders RJ. The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives. Orphanet J Rare Dis. 2012;7:83.
Cali E, Dominik N, Manole A, Houlden H. Riboflavin Transporter Deficiency. 2015 Jun 11 [Updated 2021 Apr 8]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021.
Foley AR, Menezes MP, Pandraud A et al. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain. 2014;137:44-56.
Garg M, Kulkarni SD, Hegde AU, Shah KN. Riboflavin treatment in genetically proven Brown-Vialetto-Van Laere syndrome. J Pediatr Neurosci. 2018;13:471-473.
Chiong MA, Sim KG, Carpenter K et al. Transient multiple acyl-CoA dehydrogenation deficiency in a newborn female caused by maternal riboflavin deficiency. Molec Genet Metab. 2007;92: 109-114.
Schiff M, Veauville-Merllié A, Su CH et al. SLC25A32 Mutations and Riboflavin-Responsive Exercise Intolerance. N Engl J Med. 2016;374(8):795-797.
Olsen RKJ, Koňaříková E, Giancaspero TA et al. Riboflavin-Responsive and Non-responsive Mutations in FAD Synthase Cause Multiple Acyl-CoA Dehydrogenase and Combined Respiratory-Chain Deficiency. Am J Hum Genet. 2016;98(6):1130-1145.
Yazdanpanah B, Wiegmann K, Tchikov V et al. Riboflavin kinase couples TNF receptor 1 to NADPH oxidase. Nature. 2009;460:1159-1163.
Clayton PT. B6-responsive disorders: a model of vitamin dependency. J Inherit Metab Dis. 2006;29(2-3):317-326.
Wilson MP, Plecko B, Mills PB, Clayton PT. Disorders affecting vitamin B6 metabolism. J Inherit Metab Dis. 2019;42(4):629-646.
Spector R, Johanson CE. Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E. J Neurochem. 2007;103(2):425-438.
Gospe SM Jr. Pyridoxine-Dependent Epilepsy. 2001 Dec 7 [Updated 2017 Apr 13]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021.
van Karnebeek CD, Tiebout SA, Niermeijer J et al. Pyridoxine-Dependent Epilepsy: An Expanding Clinical Spectrum. Pediatr Neurol. 2016;59:6-12.
Mills PB, Footitt EJ, Mills KA et al. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency). Brain. 2010;133(Pt7):2148-2159.
Toldo I, Bonardi CM, Bettella E et al. Brain malformations associated to Aldh7a1 gene mutations: Report of a novel homozygous mutation and literature review. Eur J Paediatr Neurol. 2018;22(6):1042-1053.
Mills PB, Struys E, Jakobs C et al. Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med. 2006;12(3):307-309.
Stockler S, Plecko B, Gospe SM Jr et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab. 2011;104(1-2):48-60.
van de Ven S, Gardeitchik T, Kouwenberg D, Kluijtmans L, Wevers R, Morava E. Long-term clinical outcome, therapy and mild mitochondrial dysfunction in hyperprolinemia. J Inherit Metab Dis. 2014;37:383-390.
Kuo MF, Wang HS. Pyridoxal phosphate-responsive epilepsy with resistance to pyridoxine. Pediatr Neurol. 2002;26:146-147.
Mills PB, Surtees RA, Champion MP et al. Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase. Hum Mol Genet. 2005;14(8):1077-1086.
Plecko B, Paul K, Mills P, et al. Pyridoxine responsiveness in novel mutations of the PNPO gene. Neurology 2014;82(16):1425–1433.
Nielsen MJ, Rasmussen MR, Andersen CB, Nexø E, Moestrup SK. Vitamin B12 transport from food to the body's cells--a sophisticated, multistep pathway. Nat Rev Gastroenterol Hepatol. 2012;9(6):345-354.
Green R, Allen LH, Bjørke-Monsen AL et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:17040.
Martinelli D, Deodato F, Dionisi-Vici C. Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis. 2011;34(1):127-135.
Thauvin-Robinet C, Roze E, Couvreur G et al. The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum. J Neurol Neurosurg Psychiatry. 2008;79(6):725-728.
Coelho D, Suormala T, Stucki M et al. Gene identification for the cblD defect of vitamin B12 metabolism. N Engl J Med. 2008;358:1454-1464.
Watkins D, Rosenblatt DS. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet. 2011;157C(1):33-44.
Alfadhel M, Lillquist YP, Davis C, Junker AK, Stockler-Ipsiroglu S. Eighteen-year follow-up of a patient with cobalamin F disease (cblF): report and review. Am. J. Med. Genet. 2011;155A: 2571-2577.
Rosenblatt D.S., Fowler B. Disorders of Cobalamin and Folate Transport and Metabolism. In: Fernandes J., Saudubray JM., van den Berghe G., Walter J.H. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. 2006:342-356.
Zavadakova P, Fowler B, Zeman J et al. CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families. J Inherit Metab Dis. 2002;25(6):461-476.
Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab. 2000;71(1-2):121-138.
Djukic A. Folate-responsive neurologic diseases. Pediatr Neurol. 2007;37(6):387-397.
Banka S, Blom HJ, Walter J et al. Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency. Am J Hum Genet. 2011;88(2):216-225.
Cappuccio G, Cozzolino C, Frisso G et al. Pearls & oy-sters: familial epileptic encephalopathy due to methylenetetrahydrofolate reductase deficiency. Neurology. 2014;83(3):e41-44.
Lossos A, Teltsh O, Milman T et al. Severe methylenetetrahydrofolate reductase deficiency: clinical clues to a potentially treatable cause of adult-onset hereditary spastic paraplegia. JAMA Neurol. 2014;71(7):901-904.
Diekman EF, de Koning TJ, Verhoeven-Duif NM, Rovers MM, van Hasselt PM. Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency. JAMA Neurol. 2014;71(2):188-194.
Burda P, Kuster A, Hjalmarson O et al. Characterization and review of MTHFD1 deficiency: four new patients, cellular delineation and response to folic and folinic acid treatment. J Inherit Metab Dis. 2015;38(5):863-872.
Zhao R, Aluri S, Goldman ID. The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption. Mol Aspects Med. 2017;53:57-72.
Steinfeld R, Grapp M, Kraetzner R et al. Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet. 2009;85(3):354-363.
Pope S, Artuch R, Heales S, Rahman S. Cerebral folate deficiency: Analytical tests and differential diagnosis. J Inherit Metab Dis. 2019;42(4):655-672.
